Finance

Lists
ANAB:NASDAQ
AnaptysBio Inc
48,54 USD
-0,19%
(-0,090) 1D
2-окт., 11:39:47 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANAB...
Open
48,97 USD
High
49,83 USD
Low
48,28 USD
Mkt. cap
1,45 млд
Avg. vol.
538,14 миң
Volume
69,53 миң
52-wk high
72,36 USD
52-wk low
19,65 USD
EPS
-0,88 USD
Beta
0,45
Shares outstanding
29,90 млн
No. of employees
104
Open
48,97 USD
High
49,83 USD
Low
48,28 USD
Mkt. cap
1,45 млд
Avg. vol.
538,14 миң
Volume
69,53 миң
52-wk high
72,36 USD
52-wk low
19,65 USD
EPS
-0,88 USD
Beta
0,45
Shares outstanding
29,90 млн
No. of employees
104
News stories
From web sources and news partners
About AnaptysBio Inc
CEO-
Employees104
Founded2005
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
Sector-
Websiteanaptysbio.com
Analyst ratings
Based on 7 analysts giving stock ratings to ANAB in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for ANAB in the last 3 months.
Highest
Current 48,54 USD
95,00 USD (+95,71%)
Average
80,00 USD (+64,81%)
Lowest
60,00 USD (+23,61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
60,00 USD
+23,6%
09/30/2026
David Risinger
Leerink Partners
Buy
Maintained
81,00 USD
+66,9%
09/23/2026
Etzer Darout
Barclays
Buy
Maintained
75,00 USD
+54,5%
09/22/2026
Michael Yee
UBS
Buy
Reiterated
76,00 USD
+56,6%
09/22/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
95,00 USD
+95,7%
09/22/2026
Joseph Thome
TD Cowen
Buy
Reiterated
-
-
08/25/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
93,00 USD
+91,6%
07/21/2026
David Nierengarten
Wedbush
Buy
Reiterated
75,00 USD
+54,5%
03/31/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
66,00 USD
+36%
03/30/2026
Joon Lee
Truist Financial
Hold
Maintained
50,00 USD
+3%
03/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
85,00 USD
+75,1%
03/05/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
140,00 USD
+188,4%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2026-ж. мар.
2026-ж. июн.
2026-ж. июн.
2026-ж. сен.
Revenue
25,56 млн
27,49 млн
27,49 млн
-
Cost of goods sold
33,99 млн
-2,70 млн
-
-
Cost of revenue
33,99 млн
-2,70 млн
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,20 млн
15,52 млн
-
-
Operating expense
26,20 млн
15,52 млн
-
-
Total operating expenses
60,19 млн
12,81 млн
-
-
Operating income
-34,64 млн
14,67 млн
-
-
Other non operating income
-1,00 миң
-1,00 миң
-
-
EBT including unusual items
-52,84 млн
-4,17 млн
-
-
EBT excluding unusual items
-52,84 млн
-4,17 млн
-
-
Income tax expense
40,00 миң
-181,49 млн
-
-
Effective tax rate
-0,08%
4 348,13%
-
-
Other operating expenses
-
-
-
-
Net income
-52,88 млн
183,88 млн
-
-
Net profit margin
-206,93%
668,95%
-
-
Earnings per share
-1,84
-
4,93
-
Interest and investment income
2,65 млн
1,49 млн
-
-
Interest expense
-20,86 млн
-20,33 млн
-
-
Net interest expenses
-18,21 млн
-18,85 млн
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-34,51 млн
14,68 млн
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору